President Trump also defended this week's firing of National Security Adviser Gen. Michael Flynn during a press conference Thursday. But Mr. Trump did not criticize the retired general for speaking with Russian officials before taking office. Hours later, retired Admiral Robert Harward declined an offer to replace Flynn. Jeff Pegues reports.


00


CBS

Latest News

Wall Street Journal: Japan's SoftBank Plans A Second Giant Technology Fund

Daily Mail: Sloth is cut down from a tree so tourists can hold them

Daily Mail: Grandmother, 74, attacked neighbour with a baseball bat

Daily Mail: Trump gets UK crime figures in a twist with `Islamic terrorĀ“ link blunder

CNBC: Stocks making the biggest moves premarket: GE, PG, HON, STI, PYPL & more

ChinaDaily: Foreign journalists get a glimpse of Beijing's rail transit construction

Reuters: Peru Congress passes bill to legalize medical marijuana

FOX: 400 mysterious ancient stone structures discovered in Saudi Arabia

CNN: Is this lost city a glimpse into the future?

ABC: WATCH: Kate del Castillo tells her side of 'El Chapo' story

Daily Mail: Man arrested near Denzel Washington movie set in Boston

Daily Mail: Sloth clings on for life as loggers take it from its hime

CNBC: Vogue and Vice are working together in unlikely collaboration combining grit and glamour

CTV News: Wild boars rampage through German town, injure at least 4

Reuters: Having nuclear weapons 'matter of life and death' for North Korea: RIA

Reuters: Banco Popular investors denied access to resolution documents

Reuters: BRIEF-Navistar announces launch of refinancing of its senior secured term loan

Reuters: BRIEF-Navistar announces tender offer and consent solicitation of outstanding senior notes

Reuters: BRIEF-Scorpio Bulkers announces the financing of a Kamsarmax vessel in Japan

Reuters: BRIEF-Aurinia Pharmaceuticals plans to expand voclosoprin renal franchise

Reuters: BRIEF-Gentex reports Q3 earnings per share of $0.31

Reuters: UPDATE 3-GE stock drops as profit misses, CEO cuts forecast

Reuters: BRIEF-Spero Therapeutics initiates clinical program for SPR994